Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Transplantation and Cellular Therapy|November 6, 2024
Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell TransplantationMiranda Benfield, Jiaxian He, Justin Arnall, et al.
JAMA Internal Medicine|March 27, 2013
Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a randomized trialSanjay V Desai, Leonard Feldman, Lorrel Brown, et al.
Blood|December 24, 2023
Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEALAaron T Gerds, Ruben Mesa, John M Burke, et al.
Leukemia & Lymphoma|May 2, 2022
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemiaThomas Prebet, Aaron D Goldberg, Joseph G Jurcic, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 16, 2019
Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL StudyMichael R Grunwald, John M Burke, David J Kuter, et al.
Blood Advances|June 30, 2019
Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemiaHarry P Erba, Pamela S Becker, Paul J Shami, et al.
The Pharmacogenomics Journal|November 5, 2023
Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosingJai N Patel, Myra Robinson, Sarah A Morris, et al.
Blood|November 23, 2016
A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AMLSteven Knapper, Nigel Russell, Amanda Gilkes, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 18, 2020
Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL StudyMichael R Grunwald, David J Kuter, Ivy Altomare, et al.
JCO Oncology Practice|June 16, 2022
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic MalignancyThomas G Knight, Melissa Aguiar, Myra Robinson, et al.
Pageof 9